AXDX Intrinsic Valuation and Fundamental Analysis - Accelerate Diagnostics Inc - Alpha Spread

Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.47 USD -0.68% Market Closed
Market Cap: 34.7m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Intrinsic Value

AXDX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one AXDX stock under the Base Case scenario is 1.82 USD. Compared to the current market price of 1.47 USD, Accelerate Diagnostics Inc is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AXDX Intrinsic Value
1.82 USD
Undervaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Accelerate Diagnostics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AXDX based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?
How do you feel about AXDX?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Accelerate Diagnostics Inc

Provide an overview of the primary business activities
of Accelerate Diagnostics Inc.

What unique competitive advantages
does Accelerate Diagnostics Inc hold over its rivals?

What risks and challenges
does Accelerate Diagnostics Inc face in the near future?

Has there been any significant insider trading activity
in Accelerate Diagnostics Inc recently?

Summarize the latest earnings call
of Accelerate Diagnostics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Accelerate Diagnostics Inc.

Provide P/S
for Accelerate Diagnostics Inc.

Provide P/E
for Accelerate Diagnostics Inc.

Provide P/OCF
for Accelerate Diagnostics Inc.

Provide P/FCFE
for Accelerate Diagnostics Inc.

Provide P/B
for Accelerate Diagnostics Inc.

Provide EV/S
for Accelerate Diagnostics Inc.

Provide EV/GP
for Accelerate Diagnostics Inc.

Provide EV/EBITDA
for Accelerate Diagnostics Inc.

Provide EV/EBIT
for Accelerate Diagnostics Inc.

Provide EV/OCF
for Accelerate Diagnostics Inc.

Provide EV/FCFF
for Accelerate Diagnostics Inc.

Provide EV/IC
for Accelerate Diagnostics Inc.

Show me price targets
for Accelerate Diagnostics Inc made by professional analysts.

What are the Revenue projections
for Accelerate Diagnostics Inc?

How accurate were the past Revenue estimates
for Accelerate Diagnostics Inc?

What are the Net Income projections
for Accelerate Diagnostics Inc?

How accurate were the past Net Income estimates
for Accelerate Diagnostics Inc?

What are the EPS projections
for Accelerate Diagnostics Inc?

How accurate were the past EPS estimates
for Accelerate Diagnostics Inc?

What are the EBIT projections
for Accelerate Diagnostics Inc?

How accurate were the past EBIT estimates
for Accelerate Diagnostics Inc?

Compare the revenue forecasts
for Accelerate Diagnostics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Accelerate Diagnostics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Accelerate Diagnostics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Accelerate Diagnostics Inc compared to its peers.

Compare the P/E ratios
of Accelerate Diagnostics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Accelerate Diagnostics Inc with its peers.

Analyze the financial leverage
of Accelerate Diagnostics Inc compared to its main competitors.

Show all profitability ratios
for Accelerate Diagnostics Inc.

Provide ROE
for Accelerate Diagnostics Inc.

Provide ROA
for Accelerate Diagnostics Inc.

Provide ROIC
for Accelerate Diagnostics Inc.

Provide ROCE
for Accelerate Diagnostics Inc.

Provide Gross Margin
for Accelerate Diagnostics Inc.

Provide Operating Margin
for Accelerate Diagnostics Inc.

Provide Net Margin
for Accelerate Diagnostics Inc.

Provide FCF Margin
for Accelerate Diagnostics Inc.

Show all solvency ratios
for Accelerate Diagnostics Inc.

Provide D/E Ratio
for Accelerate Diagnostics Inc.

Provide D/A Ratio
for Accelerate Diagnostics Inc.

Provide Interest Coverage Ratio
for Accelerate Diagnostics Inc.

Provide Altman Z-Score Ratio
for Accelerate Diagnostics Inc.

Provide Quick Ratio
for Accelerate Diagnostics Inc.

Provide Current Ratio
for Accelerate Diagnostics Inc.

Provide Cash Ratio
for Accelerate Diagnostics Inc.

What is the historical Revenue growth
over the last 5 years for Accelerate Diagnostics Inc?

What is the historical Net Income growth
over the last 5 years for Accelerate Diagnostics Inc?

What is the current Free Cash Flow
of Accelerate Diagnostics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Accelerate Diagnostics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Accelerate Diagnostics Inc

Current Assets 17.2m
Cash & Short-Term Investments 9.7m
Receivables 2.3m
Other Current Assets 5.1m
Non-Current Assets 5.7m
PP&E 4.8m
Other Non-Current Assets 882k
Current Liabilities 13.4m
Accounts Payable 3.8m
Accrued Liabilities 3.8m
Other Current Liabilities 5.8m
Non-Current Liabilities 44.3m
Long-Term Debt 41.1m
Other Non-Current Liabilities 3.2m
Efficiency

Earnings Waterfall
Accelerate Diagnostics Inc

Revenue
12.2m USD
Cost of Revenue
-8.9m USD
Gross Profit
3.3m USD
Operating Expenses
-46.3m USD
Operating Income
-43m USD
Other Expenses
5.1m USD
Net Income
-37.9m USD

Free Cash Flow Analysis
Accelerate Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

AXDX Profitability Score
Profitability Due Diligence

Accelerate Diagnostics Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
Positive Gross Profit
Positive 1-Year Revenue Growth
37/100
Profitability
Score

Accelerate Diagnostics Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

AXDX Solvency Score
Solvency Due Diligence

Accelerate Diagnostics Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
28/100
Solvency
Score

Accelerate Diagnostics Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AXDX Price Targets Summary
Accelerate Diagnostics Inc

Wall Street analysts forecast AXDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXDX is 1.5 USD .

Lowest
Price Target
Not Available
Average
Price Target
1.5 USD
2% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AXDX?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for AXDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about AXDX dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

AXDX Price
Accelerate Diagnostics Inc

1M 1M
-20%
6M 6M
+52%
1Y 1Y
-76%
3Y 3Y
-98%
5Y 5Y
-99%
10Y 10Y
-99%
Annual Price Range
1.47
52w Low
0.7365
52w High
6.7
Price Metrics
Average Annual Return -49.32%
Standard Deviation of Annual Returns 29.41%
Max Drawdown -100%
Shares Statistics
Market Capitalization 34.8m USD
Shares Outstanding 23 611 200
Percentage of Shares Shorted 3.94%

Competitive Landscape

Ownership

AXDX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc

Country

United States of America

Industry

Health Care

Market Cap

34.8m USD

Dividend Yield

0%

Description

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The company is headquartered in Tucson, Arizona and currently employs 220 full-time employees. The firm's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. The company detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk.

Contact

ARIZONA
Tucson
3950 S Country Club Rd Ste 470 Bldg 3-307
+13038638088.0
acceleratediagnostics.com

IPO

1993-10-27

Employees

220

Officers

See Also

Discover More
What is the Intrinsic Value of one AXDX stock?

The intrinsic value of one AXDX stock under the Base Case scenario is 1.82 USD.

Is AXDX stock undervalued or overvalued?

Compared to the current market price of 1.47 USD, Accelerate Diagnostics Inc is Undervalued by 19%.

Back to Top